MiNK Therapeutics
Developing iNKT cell therapies
- B2B
About MiNK Therapeutics
This clinical stage biopharmaceutical company pioneers allogeneic iNKT cell therapies for cancer and immune diseases with scalable off-the-shelf manufacturing capabilities
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Lexington, Massachusetts, United States
- Founded
- 2017
- Revenue
- $9.6M – $75.8MTamtam estimate
- Website
- minktherapeutics.com
MiNK Therapeutics at a glance
MiNK Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Lexington, Massachusetts, United States.
MiNK Therapeutics was founded in 2017.
MiNK Therapeutics has 11–50 employees.
MiNK Therapeutics's revenue is $9.6M – $75.8M (Tamtam estimate).
Frequently asked questions about MiNK Therapeutics
What is MiNK Therapeutics's revenue?
Tamtam estimates MiNK Therapeutics's annual revenue at $9.6M – $75.8M.
How many employees does MiNK Therapeutics have?
MiNK Therapeutics has 11–50 employees.
Where is MiNK Therapeutics headquartered?
MiNK Therapeutics is headquartered in Lexington, Massachusetts, United States.
Selling to companies like MiNK Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies